In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Doug Kass shares his thoughts on boosts to financials, and discusses what M&A speculation is doing to biotechs.
Cramer is looking for an opportunity to exit the position.
We have a president that seems likely to pursue a weaker dollar policy, and gold has surged.
Jim Cramer does not like how CEO Vicki Hollub is running the company and does not recommend buying the stock.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.